MTD Group completes acquisition of Ypsomed's pen needle and BGM businesses

Medical Technology and Devices (MTD) completed the acquisition of Ypsomed's Pen Needles and Blood Glucose Monitoring Systems businesses, initially announced in March 2024. The deal strengthens MTD's position as the world's second-largest pen needle producer, with total production capacity exceeding 2.5 billion pen needles.

“This acquisition marks a major step forward in MTD's mission to provide superior diabetes and obesity care solutions on a global scale.”prnewswire.com

• 2 sources
• prnewswire.comMTD Group completes the acquisition of Ypsomed's Pen Needles and Blood Glucose Monitoring Systems and announces a significant investment plan for its European production sitesMTD Medical Technology, DevicesAug 2, 2024
• ypsomed.comYpsomed and MTD complete the sale of the pen needle and BGM business - YpsomedJasmin GerberAug 2, 2024

Summarized from public sources; check the original articles before acting on it.